Biotech

All Articles

F 2G rears $100M for 2nd attempt to receive brand-new antifungal to market

.After F2G's initial effort to acquire a brand-new course of antifungal to market was actually thwar...

Moderna targets $1.1 B in R&ampD costs cuts, drops 5 plans among earnings pressures

.Moderna has pledged to reduce R&ampD costs by $1.1 billion through 2027. The selection to shrink th...

Sanofi's $80M bet on Fulcrum dystrophy medicine ends in phase 3 crash

.Simply four months after Sanofi bet $80 thousand in beforehand cash money on Fulcrum Therapies' los...

Oncternal assets sinks 60% among discharges, test discontinuations

.Cancer provider Oncternal Therapeutics is actually folding all its professional trials as well as g...

Roche is actually holding out hopes that its injectable weight problems possibility can inevitably illustrate 25% fat loss in late-stage test

.Roche is actually storing out chances that its own injectable weight problems possibility might ine...

Novo Nordisk hails 'amazing' weight loss result for dual-acting oral medicine in early trial

.Novo Nordisk has actually lifted the top on a phase 1 test of its own dental amylin and GLP-1 recep...

AbbVie files suit BeiGene over blood stream cancer medicine classified information

.Just a handful of short weeks after succeeding an FDA Fast Track tag for its investigational BTK de...

Lilly delivers one-two blow along with second tranche of positive records on weekly blood insulin applicant

.Shortly after a favorable records reduce for Eli Lilly's efsitora alfa, the Indianapolis-based busi...

BridgeBio cuts gene treatment budget plan as clinical data dissatisfy

.BridgeBio Pharma is actually lowering its own genetics treatment spending plan and pulling back com...

GSK relinquishes HSV vaccination really hopes after stage 2 fall short, signing over nationality to Moderna, BioNTech

.GSK's try to develop the 1st vaccine for genital herpes simplex infection (HSV) has ended in failin...